UPDATE 5-Valeant trumps Endo with $10.96 billion bid for Salix Pharma

March 16 (Reuters) - Valeant Pharmaceuticals International Inc increased its offer for Salix Pharmaceuticals Inc to $10.96 billion in cash on Monday, eclipsing Endo International Plc, the only other...